)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Travere Therapeutics
Travere Therapeutics (TVTX) investor relations material
Travere Therapeutics Stifel 2026 Virtual Immunology and Inflammation Forum summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Stifel 2026 Virtual Immunology and Inflammation Forum summary24 Sep, 2026
Leadership transition and company outlook
CEO announced planned departure due to personal health, with Bradley Campbell set to take over December 1, bringing deep rare disease experience and strong cultural fit.
Company is positioned strongly with robust commercial performance and a diversified pipeline targeting rare diseases.
FILSPARI commercial performance and market dynamics
FILSPARI saw strong demand in its first full FSGS quarter, with start forms doubling from the IgAN run-rate and broad physician adoption, including 30% new prescribers.
Uptake in FSGS is expected to reach peak sooner than IgAN due to a more severe patient population and different launch dynamics.
Gross-to-net for FSGS is expected in the mid-20% range, with more CMS exposure than IgAN but still majority commercial.
Early patient retention and broad use across FSGS subtypes signal sustained demand.
Competitive landscape and guidelines
BAFF-APRIL launches have not impeded FILSPARI's growth; KDIGO guidelines support combination therapy, driving earlier and broader treatment.
Early signs show minimal payer barriers to combination use, and ongoing data generation is expected to support positioning.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Travere Therapeutics
- FILSPARI's momentum and pipeline progress position the business for sustained growth.TVTX
12th Annual Cantor Fitzgerald Global Healthcare Conference - FILSPARI leads in rare renal diseases, with pipeline and market expansion set to accelerate.TVTXCanaccord Genuity's 46th Annual Growth Conference
- FILSPARI's 96% sales growth and pipeline expansion fueled robust Q2 results and future momentum.TVTXQ2 2026
- FILSPARI cements its role in rare kidney disease, with robust growth and pipeline innovation.TVTXGoldman Sachs 47th Annual Global Healthcare Conference 2026
- Portfolio expands with civorebrutinib, FILSPARI drives growth, and exclusivity may extend to 2037.TVTXJefferies Global Healthcare Conference 2026
- Exclusive licensing of civorebrutinib adds a best-in-class BTK inhibitor to the rare kidney pipeline.TVTXInvestor update
- FILSPARI gains full approval and strong sales; FSGS and pegtibatinase programs advance regulatory paths.TVTXGuggenheim’s Inaugural Healthcare Innovation Conference
- FILSPARI's FDA approval and robust sales fueled revenue growth, despite a net loss.TVTXQ3 2024
- FILSPARI's strong launch and regulatory momentum position it as a leading rare kidney therapy.TVTXJefferies Global Healthcare Conference 2025
Next Travere Therapeutics earnings date
Q3 202629 Oct, 2026
Travere Therapeutics
Next Travere Therapeutics earnings date
Q3 202629 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage